USD10
CATX Shares
About Perspective TherapeuticsPerspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
USD10
CATX Shares
About Perspective TherapeuticsPerspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$337.58M
OPEN PRICE
$2.93
LOW (1Y)
$1.96
HIGH (1Y)
$6.16
LOW (24H)
$2.88
HIGH (24H)
$3.01
VOLUME (24H)
$1M
32.15%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.93 | |
1 Day | $2.91 | |
1 Week | $3.02 | |
1 Month | $3.08 | |
1 Year | $4.31 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.